The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for cancer, AIDS, multiple sclerosis and other serious maladies far over the ...
CVS responds by saying regulator's latest report is 'inappropriate and misleading' The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Denouncing the $557 billion industry as “horrible middlemen,” responsible for—and “rich as hell” from— America’s incomparably high prescription drug prices, Trump vowed to get rid of ...
FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000% CVS responds by saying regulator’s latest report is ‘inappropriate and misleading’ Published: Jan. 14, 2025 at ...